Professor of Hematology
University of Iceland
Dr. Sigurdur Yngvi Kristinsson is a professor of Hematology at the University of Iceland. He serves as the principal investigator for the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM®) study, a population-based MGUS and multiple myeloma screening study. The iStopMM study is the largest myeloma study in the world in which over 80,000 individuals provided their written informed consent to participate.
In 2009, Dr. Kristinsson PhD thesis on risk factors and prognosis in patients with monoclonal gammopathies (Karolinska Institute) was named the best thesis in hematology in Sweden. He has written more than 120 research papers on hematological diseases. He has led several large population-based myeloma studies in collaboration with major research centers in Sweden, US and Iceland and is a frequent speaker at international hematology conferences, including the American Society of Hematology Annual Meeting and the European Hematology Association Congress. His prior research has shed light on several risk factors (such as family history and prior autoimmune disease), complications and outcomes of patients with MM and its precursor (such as thrombosis, fractures, bone disease, infections, and secondary malignancies).
Dr. Kristinsson has obtained a number of grants for research on plasma cell disease, for example from Marie-Curie reintegration grant (EU), ERC starting grant, ERC consolidator grant, Black Swan Research Initiative, the Swedish Cancer Society, the Karolinska Institutet Foundations, Swedish Hematology Association, and the Icelandic Centre for Research (RANNIS). He is also the first recipient of the Brian Durie Outstanding Achievement Award, issued by the IMWG (International Myeloma Working Group) in 2018.
Dr. Kristinsson current research group includes 4 PhD-students, a lab with 5 biologists, three postdocs, 6 research nurses, 3 statisticians, a project manager, a grant writer, and three support staff.
Is there a role for screening in monoclonal gammopathies?
Wednesday, September 27, 2023
10:45 AM – 10:55 AM EEST